NCT02513732View on ClinicalTrials.gov

XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Ischemic Heart DiseaseAngina PectorisCoronary Artery DiseaseMyocardial Ischemia
Interventions
DEVICE

XIENCE Xpedition 2.25 mm stent

Patients receiving XIENCE Xpedition 2.25 mm stent

Trial Locations (11)

660-0828

Hyogo Prefectural Amagasaki Hospital, Hyōgo

920-8530

Ishikawa Prefectural Central Hospital, Ishikawa

880-0834

Miyazaki Medical Association Hospital, Miyazaki

543-0035

Osaka Police Hospital, Osaka

062-0003

Hanaoka Seishu Memorial Cardiovascular Clinic, Sapporo

062-8618

JCHO Hokkaido Hospital, Sapporo

773-8502

Tokushima Red Cross Hospital, Tokushima

101-8643

Mitsui Memorial Hospital, Tokyo

105-8470

Toranomon Hospital, Tokyo

173-8606

Teikyo University Hospital, Tokyo

227-8501

Showa University Fujigaoka Hospital, Yokohama

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY